Showing results (701-710 of 779) with videos related to

Sort By:
Pageof 78
JACC. Cardiovascular Interventions|May 25, 2019
Transfemoral TAVR in Nonagenarians: From the CENTER CollaborationWieneke Vlastra, Jaya Chandrasekhar, Jeroen Vendrik, et al.
BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
The American Journal of Cardiology|February 27, 2023
Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve ImplantationMadison Edens, Yusuke Watanabe, Johny Nicolas, et al.
Journal of the American College of Cardiology|February 8, 2023
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.
The Canadian Journal of Cardiology|November 3, 2023
Prognostic Impact of Prefrailty and Frailty in Women Undergoing TAVR: Insights From the WIN-TAVI RegistryMarija Petrovic, Alessandro Spirito, Samantha Sartori, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|July 9, 2025
Corrigendum to 'Intravascular Coronary Imaging' Journal of the Society for Cardiovascular Angiography & Interventions 3;12 (2024) 102399Jennifer Rymer, J Dawn Abbott, Ziad A Ali, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
Journal of the American College of Cardiology|December 1, 2022
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and BioprosthesesMackram F Eleid, Dee Dee Wang, Amit Pursnani, et al.
Pageof 78